Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

546 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. Averill LA, et al. Among authors: ahn kh. J Affect Disord. 2022 Apr 15;303:91-97. doi: 10.1016/j.jad.2022.01.104. Epub 2022 Jan 29. J Affect Disord. 2022. PMID: 35101523 Clinical Trial.
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Abdallah CG, et al. Among authors: ahn kh. Neuropsychopharmacology. 2020 May;45(6):990-997. doi: 10.1038/s41386-020-0644-9. Epub 2020 Feb 24. Neuropsychopharmacology. 2020. PMID: 32092760 Free PMC article. Clinical Trial.
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants.
Abdallah CG, Ahn KH, Averill LA, Nemati S, Averill CL, Fouda S, Ranganathan M, Morgan PT, D'Souza DC, Mathalon DH, Krystal JH, Driesen NR. Abdallah CG, et al. Among authors: ahn kh. Neuropsychopharmacology. 2021 Jan;46(2):478-485. doi: 10.1038/s41386-020-00864-9. Epub 2020 Sep 23. Neuropsychopharmacology. 2021. PMID: 32967000 Free PMC article. Clinical Trial.
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Among authors: ahn kh. Neuropsychopharmacology. 2022 Jul;47(8):1574-1581. doi: 10.1038/s41386-022-01266-9. Epub 2022 Jan 19. Neuropsychopharmacology. 2022. PMID: 35046508 Free PMC article. Clinical Trial.
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Among authors: ahn kh. Neuropsychopharmacology. 2022 Jul;47(8):1583-1584. doi: 10.1038/s41386-022-01339-9. Neuropsychopharmacology. 2022. PMID: 35545665 Free PMC article. No abstract available.
Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Hamilton HK, et al. Among authors: ahn kh. Schizophr Res. 2018 Jan;191:87-94. doi: 10.1016/j.schres.2017.06.040. Epub 2017 Jul 12. Schizophr Res. 2018. PMID: 28711472 Free PMC article. Clinical Trial.
Probing GABA receptor function in schizophrenia with iomazenil.
Ahn K, Gil R, Seibyl J, Sewell RA, D'Souza DC. Ahn K, et al. Neuropsychopharmacology. 2011 Feb;36(3):677-83. doi: 10.1038/npp.2010.198. Epub 2010 Nov 10. Neuropsychopharmacology. 2011. PMID: 21068719 Free PMC article. Clinical Trial.
546 results